SecondWave Systems

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, SecondWave Systems sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed upper quartile by trial count

SecondWave Systems: 3 sponsored US clinical trials, 1 recruiting.

SecondWave Systems sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Rheumatoid Arthritis (RA), with 1 trials.

Upper-quartile sponsor footprint

SecondWave Systems sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the SecondWave Systems pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Rheumatoid Arthritis (RA) (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

SecondWave Systems: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

SecondWave Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share SecondWave Systems10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
SecondWave Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

SecondWave Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this SecondWave Systems page

3 registered trials is a research-attention snapshot, not an endorsement of SecondWave Systems or any single study.

  • 1 of SecondWave Systems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Rheumatoid Arthritis (RA) is the condition SecondWave Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis (RA) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

SecondWave Systems pipeline card: 3 registered trials from official public datasets.Report a data error.